End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis

Adult Male Carcinoma, Hepatocellular Premedication Antineoplastic Agents Cohort Studies 03 medical and health sciences 0302 clinical medicine Humans Clinical Investigation Chemoembolization, Therapeutic Aged Retrospective Studies Liver Neoplasms Equipment Design Middle Aged Microspheres Liver Transplantation 3. Good health Survival Rate Treatment Outcome Female Neoplasm Recurrence, Local Vascular Access Devices
DOI: 10.1007/s00270-018-2150-6 Publication Date: 2019-01-11T12:07:45Z
ABSTRACT
Pre-transplant locoregional therapy for hepatocellular carcinoma (HCC) during bridge-to-transplant impacts recurrence and survival rates following liver transplantation. Optimizing the effectiveness of transarterial chemoembolization (TACE) in this population is imperative, microvalve infusion catheters offer a means such improvement. All treatment-naive patients with solitary HCC tumors < 6.5 cm who underwent drug-eluting microspheres (DEM) TACE between 04/2015 08/2017 were retrospectively reviewed. Eighty-eight included DEM-TACE either standard end-hole (EH) or (MVI). The EH (n = 70) MVI 18) cohorts had similar baseline tumor size, laboratory values, etiologies. Initial objective response significantly higher vs. (100% 76.5%, p 0.019). There was no difference adverse events groups (p 0.265). exhibited lower AST 0.003) ALT 0.044) at 6 months. Blinded pathological analysis explanted livers showed greater concentrations within relative to surrounding tissue explants (88.7 ± 10.6%) versus (55.3 32.7%) 0.002). percentage necrosis group (89.0 2.2%) compared (56.1 44.5%) 0.006). In retrospective study single-center cohort, procedures associated improved response, increased deposition tissue, explant those performed using catheters.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (16)